Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is trading at $1.62, 14.89% higher. The 52-week range of the stock is $1.26-$8. The stock is down more than 54% year-to-date. Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs), in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Orexigen Therapeutics, Inc. (NASDAQ:OREX) skyrocketed 119.54% to $10.45 after the biotechnology company garnered the support of an advisory panel to federal regulators for Contrave, its weight-reduction drug candidate. Also, Jefferies keeps their Buy rating on Orexigen Therapeutics while they raise their price target to $17 from $12. Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of obesity. Johnson & Johnson (NYSE:JNJ) slid 0.16% to $62.21. The 52-week range of the stock is $56.86-$66.20. The stock is down more than 3% year-to-date. Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the health care field.
Negocioenlinea
tdp2664
Newsworthy Stocks
TODAY'S PRICE GOLD,OIL,DOW JONES,NASDAQ,S&P500,YHOO,GOOG,MSFT,CSCO,AAPL,RNWK,DJIA,GSPC,TWX,RUSSELL 3000,DJ WILL 5000